Clinical Trial Update: Lipoprotein Subfractions and Coronary Heart Disease During 25 Year Follow-up

View source ↗

Summary

This document reports the 25-year follow-up results of a clinical trial examining lipoprotein subfractions and coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease
• Heart Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED